HCC
Hirtle Callaghan & Co’s Merck MRK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,858
| Closed | -$294K | – | 97 |
|
|
2023
Q3 | $294K | Buy |
2,858
+177
| +7% | +$18.2K | 0.01% | 74 |
|
|
2023
Q2 | $309K | Sell |
2,681
-768
| -22% | -$88.6K | 0.01% | 72 |
|
|
2023
Q1 | $367K | Buy |
+3,449
| New | +$367K | 0.02% | 69 |
|
|
2019
Q1 | – | Sell |
-8,500
| Closed | -$649K | – | 110 |
|
|
2018
Q4 | $649K | Hold |
8,500
| – | – | 0.06% | 51 |
|
|
2018
Q3 | $603K | Hold |
8,500
| – | – | 0.05% | 52 |
|
|
2018
Q2 | $516K | Hold |
8,500
| – | – | 0.05% | 59 |
|
|
2018
Q1 | $463K | Hold |
8,500
| – | – | 0.04% | 64 |
|
|
2017
Q4 | $478K | Sell |
8,500
-184
| -2% | -$10.3K | 0.04% | 63 |
|
|
2017
Q3 | $556K | Buy |
8,684
+8,500
| +4,620% | +$544K | 0.06% | 52 |
|
|
2017
Q2 | $12K | Sell |
184
-44
| -19% | -$2.87K | ﹤0.01% | 161 |
|
|
2017
Q1 | $14K | Hold |
228
| – | – | ﹤0.01% | 161 |
|
|
2016
Q4 | $14K | Sell |
228
-11,166
| -98% | -$686K | ﹤0.01% | 126 |
|
|
2016
Q3 | $711K | Buy |
11,394
+2,500
| +28% | +$156K | 0.15% | 40 |
|
|
2016
Q2 | $512K | Sell |
8,894
-75
| -0.8% | -$4.32K | 0.1% | 51 |
|
|
2016
Q1 | $474K | Buy |
8,969
+8,385
| +1,436% | +$443K | 0.09% | 52 |
|
|
2015
Q4 | $30K | Sell |
584
-1,200
| -67% | -$61.6K | 0.01% | 140 |
|
|
2015
Q3 | $89K | Hold |
1,784
| – | – | 0.02% | 132 |
|
|
2015
Q2 | $101K | Buy |
+1,784
| New | +$101K | 0.03% | 137 |
|
|
2015
Q1 | – | Sell |
-25,244
| Closed | -$1.44M | – | 243 |
|
|
2014
Q4 | $1.44M | Sell |
25,244
-4,600
| -15% | -$262K | 0.33% | 48 |
|
|
2014
Q3 | $1.78M | Sell |
29,844
-270
| -0.9% | -$16.1K | 0.29% | 51 |
|
|
2014
Q2 | $1.75M | Hold |
30,114
| – | – | 0.24% | 61 |
|
|
2014
Q1 | $1.72M | Sell |
30,114
-200
| -0.7% | -$11.4K | 0.28% | 51 |
|
|
2013
Q4 | $1.53M | Sell |
30,314
-288
| -0.9% | -$14.5K | 0.2% | 58 |
|
|
2013
Q3 | $1.46M | Buy |
30,602
+29,402
| +2,450% | +$1.41M | 0.24% | 57 |
|
|
2013
Q2 | $56K | Buy |
+1,200
| New | +$56K | 0.65% | 33 |
|